GBT new logo.png
GBT Announces Participation at the 4th Annual Evercore ISI HealthCONx Conference
November 24, 2021 08:00 ET | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in a virtual fireside chat at the 4th...
GBT new logo.png
GBT Announces Participation in Upcoming Investor Conferences
November 12, 2021 08:00 ET | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in a virtual fireside chat at the Stifel...
GBT new logo.png
GBT Announces New Employment Inducement Grants
November 08, 2021 08:00 ET | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on November 1, 2021, the compensation committee of GBT’s board...
GBT new logo.png
GBT Reports Third Quarter 2021 Financial Results
November 04, 2021 16:05 ET | Global Blood Therapeutics, Inc.
Achieved Oxbryta® (voxelotor) net revenues of $52.1 million, a 41% increase year over year Oxbryta sNDA and NDA for pediatric label expansion accepted by FDA for priority review; PDUFA target...
GBT new logo.png
GBT Announces Six Data Presentations on Sickle Cell Disease at Upcoming 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
November 04, 2021 09:05 ET | Global Blood Therapeutics, Inc.
Accepted Abstracts Include Real-World Experience with Oxbryta® (voxelotor) and Phase 1 Data on GBT021601 and Inclacumab SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Global Blood...
GBT new logo.png
GBT Wins Prestigious Prix Galien USA Award for Oxbryta® (voxelotor)
November 01, 2021 08:00 ET | Global Blood Therapeutics, Inc.
Considered the equivalent of the Nobel Prize in biopharmaceutical research, Prix Galien USA honors Oxbryta as the Best Biotechnology Product for 2021 Oxbryta is the first and only approved therapy...
GBT new logo.png
GBT to Announce Third Quarter 2021 Financial Results on Thursday, November 4
October 28, 2021 08:00 ET | Global Blood Therapeutics, Inc.
Company to also host R&D Day on Thursday, November 11 in New York City and via video webcast SOUTH SAN FRANCISCO, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT)...
GBT new logo.png
GBT Announces New Employment Inducement Grants
October 07, 2021 08:00 ET | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on October 1, 2021, the compensation committee of GBT’s board...
GBT new logo.png
GBT Announces Participation at the Cantor Global Healthcare Conference
September 20, 2021 08:00 ET | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in a virtual fireside chat at the Cantor...
GBT new logo.png
GBT inaugure sa Fondation, pour améliorer la santé et le bien-être de communautés de patients défavorisés le monde
September 14, 2021 11:00 ET | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., 14 sept. 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics Inc. (GBT) (NASDAQ: GBT) a annoncé le lancement de sa Fondation, une organisation dédiée à améliorer la santé...